FDA.reportPublic FDA data

RYTARY 48.75 MG / 195 MG 8HR Extended Release Oral Capsule

RxCUI
1600915
RxNorm name
RYTARY 48.75 MG / 195 MG 8HR Extended Release Oral Capsule
Display name
RYTARY 48.75 MG / 195 MG 8HR Extended Release Oral Capsule
Full name
RYTARY 48.75 MG / 195 MG 8HR Extended Release Oral Capsule
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RYTARYCARBIDOPA AND LEVODOPAAmneal Pharmaceuticals LLC6c1f7cd4-de56-45c1-a734-5e77b4aeb6f72026-03-26Warnings, Adverse reactionsExact identifier
rxcui: 1600915

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
6c1f7cd4-de56-45c1-a734-5e77b4aeb6f7RYTARY 48.75 MG / 195 MG 8HR Extended Release Oral Capsule [PSN] · 8 HR carbidopa 48.75 MG / levodopa 195 MG Extended Release Oral Capsule [Rytary] [SBD] · 8 HR Carbidopa 48.75 MG / L-DOPA 195 MG Extended Release Oral Capsule [Rytary] [SY] · Rytary (carbidopa 48.75 MG / levodopa 195 MG) 8 HR Extended Release Oral Capsule [SY]426These highlights do not include all the information needed to use RYTARY safely and effectively. See full prescribing information for RYTARY. RYTARY (carbidopa and levodopa) extended-release capsules, for oral use Initial U.S. Approval: 197520260326